Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009)
- PMID: 27547682
- PMCID: PMC4978656
- DOI: 10.1186/s40064-016-2986-7
Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009)
Abstract
Background: Multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii are common causes of health care associated infections worldwide. Carbapenems are effective against infections caused by multidrug resistant Gram-negative bacteria including Pseudomonas and Acinetobacter species. However, their use is threatened by the emergence of carbapenemase-producing strains. The aim of this study was to determine the prevalence of carbapenem-resistant P. aeruginosa and A. baumannii at Mulago Hospital in Kampala Uganda, and to establish whether the hospital environment harbors carbapenem-resistant Gram-negative rods.
Results: Between February 2007 and September 2009, a total of 869 clinical specimens were processed for culture and sensitivity testing yielding 42 (5 %) P. aeruginosa and 29 (3 %) A. baumannii isolates, of which 24 % (10/42) P. aeruginosa and 31 % (9/29) A. baumannii were carbapenem-resistant. Additionally, 80 samples from the hospital environment were randomly collected and similarly processed yielding 58 % (46/80) P. aeruginosa and 14 % (11/80) A. baumannii, of which 33 % (15/46) P. aeruginosa and 55 % (6/11) A. baumannii were carbapenem-resistant. The total number of isolates studied was 128. Carbapenemase genes detected were bla IMP-like (36 %, 9/25), bla VIM-like (32 %, 8/25), bla SPM-like (16 %, 4/25); bla NDM-1-like (4 %, 1/25) in carbapenem-resistant P. aeruginosa, and bla OXA-23-like (60 %, 9/15), bla OXA-24-like (7 %, 1/15), bla OXA-58-like (13 %, 2/15), and bla VIM-like (13 %, 2/15) in carbapenem-resistant A. baumannii. Furthermore, class 1 integrons were detected in 38 % (48/128) of P. aeruginosa and Acinetobacter, 37 % (26/71) of which were in clinical isolates and 39 % (22/57) in environment isolates. Gene cassettes were found in 25 % (12/48) of integron-positive isolates. These were aminoglycoside adenylyltransferase ant(4')-IIb (3 isolates); trimethoprim-resistant dihydrofolate reductase dfrA (2 isolates); adenyltransferase aadAB (3 isolates); QacE delta1 multidrug exporter (2 isolates); quinolone resistance pentapeptide repeat protein qnr (1 isolate); and metallo-β-lactamase genes bla VIM-4-like, bla IMP-19-like, and bla IMP-26-like (1 isolate each). Gene cassettes were missing in 75 % (36/48) of the integron-positive isolates.
Conclusions: The prevalence of carbapenem-resistant P. aeruginosa and Acinetobacter among hospitalized patients at Mulago Hospital is low compared to rates from South-East Asia. However, it is high among isolates and in the environment, which is of concern given that the hospital environment is a potential source of infection for hospitalized patients and health care workers.
Keywords: Carbapenemase genes; Class 1 integrons; Hospital environment; Metallo-beta-lactamases; OXA-carbapenemases.
Similar articles
-
blaVIM- and blaOXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda.BMC Infect Dis. 2019 Oct 16;19(1):853. doi: 10.1186/s12879-019-4510-5. BMC Infect Dis. 2019. PMID: 31619192 Free PMC article.
-
Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.BMC Res Notes. 2017 Jul 14;10(1):284. doi: 10.1186/s13104-017-2612-y. BMC Res Notes. 2017. PMID: 28705201 Free PMC article.
-
Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt.Antimicrob Resist Infect Control. 2019 Nov 20;8:185. doi: 10.1186/s13756-019-0611-6. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31832185 Free PMC article.
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372099 Free PMC article. Review.
-
Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge.Emerg Microbes Infect. 2022 Dec;11(1):811-814. doi: 10.1080/22221751.2022.2048972. Emerg Microbes Infect. 2022. PMID: 35240944 Free PMC article. Review.
Cited by
-
Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One. 2023 Nov 28;18(11):e0287762. doi: 10.1371/journal.pone.0287762. eCollection 2023. PLoS One. 2023. PMID: 38015906 Free PMC article.
-
Co-existence of blaIMP, blaNDM-1, and blaSHV, genes of Pseudomonas aeruginosa isolated from Quetta: Antimicrobial resistance and clinical significance.Pak J Med Sci. 2023 Sep-Oct;39(5):1507-1511. doi: 10.12669/pjms.39.5.7188. Pak J Med Sci. 2023. PMID: 37680816 Free PMC article.
-
A case for routine microbial diagnostics: Results from antimicrobial susceptibility testing in post-traumatic wound infections at a Ugandan tertiary care hospital.PLOS Glob Public Health. 2023 Aug 15;3(8):e0001880. doi: 10.1371/journal.pgph.0001880. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37582103 Free PMC article.
-
Emergence of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Gram Negative Non-Fermenters at Selected Hospitals of Northeast Ethiopia: A Prospective Cross-Sectional Study.Infect Drug Resist. 2023 Jul 27;16:4891-4901. doi: 10.2147/IDR.S407151. eCollection 2023. Infect Drug Resist. 2023. PMID: 37534064 Free PMC article.
-
Klebsiella pneumoniae carbapenamases in Escherichia coli isolated from humans and livestock in rural south-western Uganda.PLoS One. 2023 Jul 13;18(7):e0288243. doi: 10.1371/journal.pone.0288243. eCollection 2023. PLoS One. 2023. PMID: 37440483 Free PMC article.
References
-
- Carroll KC, Glanz BD, Borek AP, Burger C, Bhally HS, Henciak S, Flayhart D. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae. J Clin Microbiol. 2006;44(10):3506–3509. doi: 10.1128/JCM.00994-06. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
